doi:10.3390/ijms20051105 48
In: Epigenetics of cancer prevention
Masi, A., Glozier, N., Dale, R
AS reports grants and consultancy from Gilead, grants and consultancy from Intercept, grants and consultancy from Novartis, grants from Merck, grants and consultancy from BMS, grants from Tobira, grants from Echosens, board membership from Sanyal Bio, board membership and stocks from Genfit, board membership and stocks from Tiziana, consultancy from Galectin, consultancy from Nitto Denko, consultancy from Nimbus, consultancy from Ardelyx, consultancy from Vivelix, consultancy from Teva, consultancy from CanFite, consultancy from Boehringer Ingelheim, consultancy from Pfizer, consultancy from Salix, consultancy from Enyo, royalties from UpToDate, stocks in Natural Shield, stocks in Durect, stocks in Exalenz, stocks in HemoShear and stocks in Akarna, outside the submitted work
Biomark Med 5:497514 Smyth R, Turton JA, Clarke CJ, York MJ, Dare TO, Lane CS, Munday MR (2008) Identification of superoxide dismutase as a potential urinary marker of carbon tetrachloride-induced hepatic toxicity
